Free Trial

PetVivo (PETV) Competitors

PetVivo logo
$0.52 +0.05 (+9.90%)
As of 11/13/2026 03:39 PM Eastern

PETV vs. NRXS, HYPR, OM, MBOT, and LNSR

Should you buy PetVivo stock or one of its competitors? PetVivo's main competitors and comparable companies include NeurAxis (NRXS), Hyperfine (HYPR), Outset Medical (OM), Microbot Medical (MBOT), and LENSAR (LNSR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does PetVivo compare to NeurAxis?

PetVivo (NASDAQ:PETV) and NeurAxis (NASDAQ:NRXS) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, institutional ownership, risk and profitability.

PetVivo has higher earnings, but lower revenue than NeurAxis. NeurAxis is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PetVivo$1.05M18.97-$10.95M-$0.34N/A
NeurAxis$6.53M10.42-$14.63M-$1.06N/A

NeurAxis has a net margin of -492.76% compared to PetVivo's net margin of -902.82%. NeurAxis' return on equity of 0.00% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
PetVivo-902.82% -4,813.07% -281.78%
NeurAxis -492.76%N/A -641.25%

PetVivo has a beta of 1.41, indicating that its share price is 41% more volatile than the broader market. Comparatively, NeurAxis has a beta of 1.39, indicating that its share price is 39% more volatile than the broader market.

24.5% of PetVivo shares are owned by institutional investors. Comparatively, 11.8% of NeurAxis shares are owned by institutional investors. 10.8% of PetVivo shares are owned by insiders. Comparatively, 21.1% of NeurAxis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

NeurAxis has a consensus target price of $13.00, indicating a potential upside of 139.85%. Given NeurAxis' stronger consensus rating and higher possible upside, analysts plainly believe NeurAxis is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
NeurAxis
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, NeurAxis had 3 more articles in the media than PetVivo. MarketBeat recorded 5 mentions for NeurAxis and 2 mentions for PetVivo. NeurAxis' average media sentiment score of 0.16 beat PetVivo's score of 0.00 indicating that NeurAxis is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PetVivo
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
NeurAxis
0 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

NeurAxis beats PetVivo on 9 of the 16 factors compared between the two stocks.

How does PetVivo compare to Hyperfine?

PetVivo (NASDAQ:PETV) and Hyperfine (NASDAQ:HYPR) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

In the previous week, Hyperfine had 7 more articles in the media than PetVivo. MarketBeat recorded 9 mentions for Hyperfine and 2 mentions for PetVivo. Hyperfine's average media sentiment score of 0.12 beat PetVivo's score of 0.00 indicating that Hyperfine is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PetVivo
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Hyperfine
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
2 Very Negative mention(s)
Neutral

PetVivo has higher earnings, but lower revenue than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PetVivo$1.05M18.97-$10.95M-$0.34N/A
Hyperfine$11.40M5.85-$35.57M-$0.30N/A

Hyperfine has a net margin of -156.42% compared to PetVivo's net margin of -902.82%. Hyperfine's return on equity of -91.18% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
PetVivo-902.82% -4,813.07% -281.78%
Hyperfine -156.42%-91.18%-55.49%

Hyperfine has a consensus price target of $2.03, indicating a potential upside of 221.79%. Given Hyperfine's stronger consensus rating and higher probable upside, analysts clearly believe Hyperfine is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Hyperfine
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.67

PetVivo has a beta of 1.41, meaning that its share price is 41% more volatile than the broader market. Comparatively, Hyperfine has a beta of 1.49, meaning that its share price is 49% more volatile than the broader market.

24.5% of PetVivo shares are held by institutional investors. Comparatively, 15.0% of Hyperfine shares are held by institutional investors. 10.8% of PetVivo shares are held by company insiders. Comparatively, 26.3% of Hyperfine shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Hyperfine beats PetVivo on 13 of the 17 factors compared between the two stocks.

How does PetVivo compare to Outset Medical?

Outset Medical (NASDAQ:OM) and PetVivo (NASDAQ:PETV) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.

Outset Medical presently has a consensus target price of $10.00, suggesting a potential upside of 168.10%. Given Outset Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe Outset Medical is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Outset Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Outset Medical has a net margin of -58.33% compared to PetVivo's net margin of -902.82%. Outset Medical's return on equity of -66.98% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
Outset Medical-58.33% -66.98% -28.40%
PetVivo -902.82%-4,813.07%-281.78%

24.5% of PetVivo shares are held by institutional investors. 2.5% of Outset Medical shares are held by insiders. Comparatively, 10.8% of PetVivo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

PetVivo has lower revenue, but higher earnings than Outset Medical. PetVivo is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Outset Medical$119.48M0.59-$81.65M-$3.87N/A
PetVivo$1.05M18.97-$10.95M-$0.34N/A

In the previous week, Outset Medical and Outset Medical both had 2 articles in the media. Outset Medical's average media sentiment score of 0.56 beat PetVivo's score of 0.00 indicating that Outset Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Outset Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PetVivo
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Outset Medical has a beta of 1.93, indicating that its stock price is 93% more volatile than the broader market. Comparatively, PetVivo has a beta of 1.41, indicating that its stock price is 41% more volatile than the broader market.

Summary

Outset Medical beats PetVivo on 10 of the 15 factors compared between the two stocks.

How does PetVivo compare to Microbot Medical?

Microbot Medical (NASDAQ:MBOT) and PetVivo (NASDAQ:PETV) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, media sentiment, valuation, risk, analyst recommendations and institutional ownership.

Microbot Medical has a beta of 1.07, suggesting that its stock price is 7% more volatile than the broader market. Comparatively, PetVivo has a beta of 1.41, suggesting that its stock price is 41% more volatile than the broader market.

Microbot Medical has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. Microbot Medical's return on equity of -21.87% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
Microbot MedicalN/A -21.87% -20.76%
PetVivo -902.82%-4,813.07%-281.78%

16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 24.5% of PetVivo shares are held by institutional investors. 3.9% of Microbot Medical shares are held by company insiders. Comparatively, 10.8% of PetVivo shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Microbot Medical had 2 more articles in the media than PetVivo. MarketBeat recorded 4 mentions for Microbot Medical and 2 mentions for PetVivo. Microbot Medical's average media sentiment score of 0.07 beat PetVivo's score of 0.00 indicating that Microbot Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Microbot Medical
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
PetVivo
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

PetVivo has higher revenue and earnings than Microbot Medical. Microbot Medical is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbot MedicalN/AN/A-$13.14M-$0.24N/A
PetVivo$1.05M18.97-$10.95M-$0.34N/A

Microbot Medical currently has a consensus price target of $5.08, indicating a potential upside of 419.40%. Given Microbot Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Microbot Medical is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Microbot Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Microbot Medical beats PetVivo on 9 of the 15 factors compared between the two stocks.

How does PetVivo compare to LENSAR?

PetVivo (NASDAQ:PETV) and LENSAR (NASDAQ:LNSR) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, valuation and profitability.

LENSAR has a net margin of 56.07% compared to PetVivo's net margin of -902.82%. LENSAR's return on equity of 1,254.25% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
PetVivo-902.82% -4,813.07% -281.78%
LENSAR 56.07%1,254.25%49.13%

LENSAR has a consensus price target of $11.00, indicating a potential upside of 120.00%. Given LENSAR's stronger consensus rating and higher possible upside, analysts clearly believe LENSAR is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
LENSAR
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

In the previous week, LENSAR had 15 more articles in the media than PetVivo. MarketBeat recorded 17 mentions for LENSAR and 2 mentions for PetVivo. PetVivo's average media sentiment score of 0.00 beat LENSAR's score of -0.25 indicating that PetVivo is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PetVivo
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
LENSAR
0 Very Positive mention(s)
3 Positive mention(s)
5 Neutral mention(s)
6 Negative mention(s)
0 Very Negative mention(s)
Neutral

24.5% of PetVivo shares are held by institutional investors. Comparatively, 40.2% of LENSAR shares are held by institutional investors. 10.8% of PetVivo shares are held by company insiders. Comparatively, 65.8% of LENSAR shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

PetVivo has a beta of 1.41, suggesting that its share price is 41% more volatile than the broader market. Comparatively, LENSAR has a beta of 1.03, suggesting that its share price is 3% more volatile than the broader market.

PetVivo has higher earnings, but lower revenue than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PetVivo$1.05M18.97-$10.95M-$0.34N/A
LENSAR$58.44M1.05-$34.28M-$0.40N/A

Summary

LENSAR beats PetVivo on 10 of the 16 factors compared between the two stocks.

Get PetVivo News Delivered to You Automatically

Sign up to receive the latest news and ratings for PETV and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PETV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PETV vs. The Competition

MetricPetVivoHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$19.85M$5.98B$7.87B$12.20B
Dividend YieldN/A1.68%2.46%4.55%
P/E Ratio-1.1439.3334.5630.64
Price / Sales18.975.548.335.73
Price / CashN/A23.9521.9322.49
Price / Book-17.174.454.353.76
Net Income-$10.95M$143.92M$3.52B$390.95M
7 Day Performance-12.59%-1.14%-1.52%-0.34%
1 Month Performance-30.41%-2.38%-3.54%-5.79%
1 Year Performance-61.28%1.91%1.45%-5.71%

PetVivo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PETV
PetVivo
N/A$0.52
+9.9%
N/AN/A$19.85M$1.05MN/A22
NRXS
NeurAxis
2.7562 of 5 stars
$6.24
+2.1%
$13.00
+108.3%
N/A$78.36M$5.32MN/A24
HYPR
Hyperfine
2.1039 of 5 stars
$0.72
+5.0%
$2.03
+181.4%
N/A$76.85M$11.40MN/A102
OM
Outset Medical
3.3775 of 5 stars
$4.23
+3.2%
$10.00
+136.4%
N/A$75.57M$119.48MN/A310
MBOT
Microbot Medical
2.7549 of 5 stars
$1.11
+3.7%
$5.08
+358.0%
N/A$69.85MN/AN/A22

Related Companies and Tools


This page (NASDAQ:PETV) was last updated on 11/15/2026 by MarketBeat.com Staff.
From Our Partners